BANK VONTOBEL/PUT/STRYKER CORP./320/0.1/20.12.24 Share Price

Warrant

DE000VD3SNN1

Real-time Boerse Frankfurt Warrants 09:30:44 04/07/2024 BST
1.14 EUR -2.56% Intraday chart for BANK VONTOBEL/PUT/STRYKER CORP./320/0.1/20.12.24
Current month+14.71%
1 month+8.33%
Date Price Change
04/07/24 1.14 -2.56%
03/07/24 1.17 +0.86%
02/07/24 1.16 +7.41%
01/07/24 1.08 +5.88%
28/06/24 1.02 +3.03%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 09:30 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SNN
ISINDE000VD3SNN1
Date issued 09/04/2024
Strike 320 $
Maturity 20/12/2024 (170 Days)
Parity 10 : 1
Emission price 1.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.02
Lowest since issue 0.78
Spread 0.04
Spread %3.33%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
332 USD
Average target price
372.7 USD
Spread / Average Target
+12.27%
Consensus